Sodelglitazar

Overview

Sodelglitazar (GW 677954) is a pan- PPAR agonist with potential applications in the treatment of hyperlipidemia and type 2 diabetes.

Application

Products | Products > Disease Areas > Hyperlipidemia | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Type 2 Diabetes | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > PPAR

Product Information

• Catalog No.: HY-14935
• CAS No.: 447406-78-2
• Molecular Formula: C23H21F4NO3S2
• Molecular Weight: 499.54
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source